Is Tarsus Pharmaceuticals TARS stock failing to hold levels Tarsus Pharmaceuticals posts wider than expected EPS loss CVSA Covista delivers 89 percent first quarter 2026 EPS beat shares rise modestly on upbeat investor reaction CMCO Columbus Q1 2026 earnings per share tops estimates by 43 percent stock gains 132 percent